Next 10 |
home / stock / soph / soph articles
Shares of Bank of Montreal (NYSE:BMO) fell sharply during Wednesday's session after the company reported worse-than-expected second-quarter fi...
U.S. stocks were lower, with the Dow Jones index falling more than 300 points on Wednesday. Shares of HEICO Corporation (NYSE:HEI) rose sharply dur...
BOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven m...
The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland, April 4, 2024 /PRNewswir...
BOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (NASDAQ:SOPH), a cloud-native software company and a leader in...
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. United Natural F...
Shares of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) shares surged 24.4% to $370.27 in pre-market trading after the company reported better-than-ex...
U.S. stock futures were higher this morning, with the Nasdaq futures gaining by around 100 points on Wednesday. Shares of Oddity Tech Ltd. (NASDA...
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quar...
News, Short Squeeze, Breakout and More Instantly...
India-Based Dhiti Omics is Now Live on SOPHiA DDM™ PR Newswire The diagnostics company has implemented the SOPHiA DDM ™ Platform to enhance its solid tumor testing BOSTON and ROLLE, Switzerland , July 4, 2024 /PRNewswire/ -- SO...
BOSTON and ROLLE, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a healthcare technology company and a leader in data-driven medicine, is pleased to announce that its annual general meeting of shareholders (the “ AGM ”) was held at the Company&...
SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application PR Newswire Novel application supports measurable residual disease (MRD) testing to help monitor cancer and stay ahead of relapse BOSTON and ROLLE, Switzerland , June 24, 2024 ...